Market Overview

ZappRx Successfully Advances its Service Organization Control (SOC) 2 Type 2 Report, Validating Secure and Protected Data Exchange

Share:

SOC 2 Type 2 adaptation demonstrates health tech leader's commitment
to compliance and security of protected patient information

ZappRx,
Inc.
, a digital health company that streamlines the prescribing of
specialty medications, has completed SOC
2 Type 2
attestation after satisfying the requirements defined by
the Association
of International Certified Professional Accountants
(AICPA). The
audit, performed by a major global CPA firm, verifies that ZappRx has
built an effective platform that complies with the standards for the
security required to process and control digital prescribing and prior
authorization for specialty medications.

The SOC 2 Type 2 report provides valuable information for ZappRx to
properly assess and address the risks associated with an outsourced
service. The report covers five principles against which companies are
evaluated. ZappRx was assessed across two of those principles, security
and privacy, and achieved compliance with both. The audit examined those
specific principles and determined ZappRx satisfied the applicable AICPA
criteria.

"We are committed to upholding industry-recognized security and privacy
standards to ensure the protection of our customers' most sensitive
information," said Kyle Kruczek, director of information security at
ZappRx. "We apply the most rigid security technology possible in every
aspect of our business to ensure patient information remains protected.
By achieving SOC 2 Type 2, we have validated for our customers that
ZappRx meets the standards set by the AICPA and they can put trust in
our solution."

ZappRx's commitment to meeting the highest standards in data security,
compliance, and risk management is further demonstrated by this latest
audit to obtain SOC 2 Type 2. The company conducts regular threat
assessments and ongoing system-wide monitoring to ensure the protection
of client and patient data.

By achieving SOC 2 Type 2, ZappRx enhances its competitive edge as it
continues to expand its services for healthcare providers, biopharma
companies, and specialty pharmacies.

About ZappRx

ZappRx streamlines the complex process required to order specialty
medications, increasing efficiencies when collecting and maintaining the
myriad requisite information for specialty prescribing — including
pharmacy information, payer/prior authorization requirements, and
relevant clinical history. ZappRx then enables providers, pharmacists,
and payers to digitally interact with one another to fill a
prescription, reducing the need for faxes and phone calls. The platform
is currently live in three disease areas, including Pulmonary Arterial
Hypertension (PAH), Idiopathic Pulmonary Fibrosis (IPF), and Cystic
Fibrosis, with plans to expand to support prescribing for other areas,
including gastroenterology, rheumatology, neurology, and oncology
conditions.

Connect with ZappRx on Twitter and LinkedIn.

View Comments and Join the Discussion!